$
9.62
11:34 AM EST
New Key Statistics Module, Z-Score and F-Score
OTCPK:SNPHY Key Ratios
Market Cap $ M | 3,748.33 |
Enterprise Value $ M | 3,196.97 |
P/E(ttm) | 22.08 |
PE Ratio without NRI | 22.08 |
Forward PE Ratio | 15.56 |
Price/Book | 2.01 |
Price/Sales | 2.01 |
Price/Free Cash Flow | 9.62 |
Price/Owner Earnings | 13.94 |
Payout Ratio % | 0.44 |
Revenue (TTM) $ M | 2,037.00 |
EPS (TTM) $ | 0.49 |
Beneish M-Score | -3.27 |
10-y EBITDA Growth Rate % | -3.50 |
5-y EBITDA Growth Rate % | -9.60 |
y-y EBITDA Growth Rate % | -6.10 |
EV-to-EBIT | 13.22 |
EV-to-EBITDA | 8.51 |
PEG | -- |
Shares Outstanding M | 342.94 |
Net Margin (%) | 8.64 |
Operating Margin % | 12.33 |
Pre-tax Margin (%) | 9.80 |
Quick Ratio | 1.97 |
Current Ratio | 2.61 |
ROA % (ttm) | 6.15 |
ROE % (ttm) | 8.70 |
ROIC % (ttm) | 11.16 |
Dividend Yield % | 2.00 |
Altman Z-Score | 4.91 |
SNPHY Number of Guru Trades
SNPHY Volume of Guru Trades
Gurus Latest Trades with OTCPK:SNPHY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:SNPHY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Santen Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about OTCPK:SNPHY
Total 0- 1